Literature DB >> 19410288

High performance mRNA transfection through carbonate apatite-cationic liposome conjugates.

Fatema T Zohra1, Ezharul H Chowdhury, Toshihiro Akaike.   

Abstract

mRNA instead of DNA provides a new and attractive approach for gene therapy and genetic vaccination. Delivery of mRNA can bypass nuclear localization step enabling protein expression directly in cytoplasm through transcription. Current technologies for mRNA delivery are predominantly based on cationic liposomes with low activity for transfection. We, previously reported that applying inorganic nano-particles of carbonate apatite onto cationic liposome of DOTAP {N-[1-(2,3-dioleoloxy)propyl]-N,N,N-trimethyl ammonium chloride} resulted in high transfection potency for luciferase mRNA both in mitotic and non-mitotic cells. In this paper, we expanded the previous work and performed in detail study especially on two important parts, evaluating the image of the complex and analyzing the steps of gene delivery to detect the determinant factor for enhanced transfection potency. Transmission electron microscopic (TEM) observation clearly indicated the presence of inorganic carbonate apatite particles on mRNA-liposome complex and demonstrated the structure of the new hybrid carrier material. Due to apparently higher gravitational force of absorbed inorganic nano-particles, cellular contact and internalization of hybrid-particle-associated mRNA were significantly enhanced compared to DOTAP. This analysis indicates rather than downstream steps, initial steps of cell membrane binding and subsequent way of internalization could be the determinant factor for final protein expression. Moreover, we compared transfection efficiency of mRNA and pDNA in Human Umbilical Vein Endothelial cell (HUVEC) to demonstrate advantages of mRNA delivery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19410288     DOI: 10.1016/j.biomaterials.2009.02.050

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  16 in total

1.  Inorganic nanovectors for nucleic acid delivery.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Anisha A D'Souza; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

Review 2.  Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.

Authors:  S Guan; J Rosenecker
Journal:  Gene Ther       Date:  2017-01-17       Impact factor: 5.250

3.  PEGylation improves nanoparticle formation and transfection efficiency of messenger RNA.

Authors:  Senta Uzgün; Gabriela Nica; Corinna Pfeifer; Michele Bosinco; Kai Michaelis; Jean-François Lutz; Marc Schneider; Joseph Rosenecker; Carsten Rudolph
Journal:  Pharm Res       Date:  2011-05-19       Impact factor: 4.200

4.  In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles.

Authors:  Xingfang Su; Jennifer Fricke; Daniel G Kavanagh; Darrell J Irvine
Journal:  Mol Pharm       Date:  2011-04-01       Impact factor: 4.939

5.  Biomaterials for mRNA delivery.

Authors:  Mohammad Ariful Islam; Emma K G Reesor; Yingjie Xu; Harshal R Zope; Bruce R Zetter; Jinjun Shi
Journal:  Biomater Sci       Date:  2015-08-17       Impact factor: 6.843

6.  Inhibition of Xenograft tumor growth by gold nanoparticle-DNA oligonucleotide conjugates-assisted delivery of BAX mRNA.

Authors:  Ji-Hyun Yeom; Sang-Mi Ryou; Miae Won; Mira Park; Jeehyeon Bae; Kangseok Lee
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

7.  In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.

Authors:  Meike-Kristin Abraham; Andrea Nolte; Rebekka Reus; Andreas Behring; Diane Zengerle; Meltem Avci-Adali; Jan David Hohmann; Karlheinz Peter; Christian Schlensak; Hans Peter Wendel; Stefanie Krajewski
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

8.  Self-assembled Messenger RNA Nanoparticles (mRNA-NPs) for Efficient Gene Expression.

Authors:  Hyejin Kim; Yongkuk Park; Jong Bum Lee
Journal:  Sci Rep       Date:  2015-08-03       Impact factor: 4.379

9.  Nanoliposomes for Safe and Efficient Therapeutic mRNA Delivery: A Step Toward Nanotheranostics in Inflammatory and Cardiovascular Diseases as well as Cancer.

Authors:  Meike-Kristin Abraham; Karlheinz Peter; Tatjana Michel; Hans Peter Wendel; Stefanie Krajewski; Xiaowei Wang
Journal:  Nanotheranostics       Date:  2017-04-05

10.  Allergen-Specific Immunotherapy With Liposome Containing CpG-ODN in Murine Model of Asthma Relies on MyD88 Signaling in Dendritic Cells.

Authors:  Ricardo Wesley Alberca-Custodio; Lucas D Faustino; Eliane Gomes; Fernanda Peixoto Barbosa Nunes; Mirian Krystel de Siqueira; Alexis Labrada; Rafael Ribeiro Almeida; Niels Olsen Saraiva Câmara; Denise Morais da Fonseca; Momtchilo Russo
Journal:  Front Immunol       Date:  2020-04-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.